Navigation Links
Inovio Pharmaceuticals Reports Long-Term Immune Responses from Therapeutic Cervical Dysplasia and Cancer DNA Vaccine
Date:5/9/2011

our capital resources, the availability or potential availability of alternative therapies or treatments for the conditions targeted by the company or its collaborators, including alternatives that may be more efficacious or cost-effective than any therapy or treatment that the company and its collaborators hope to develop, evaluation of potential opportunities, issues involving product liability, issues involving patents and whether they or licenses to them will provide the company with meaningful protection from others using the covered technologies, whether such proprietary rights are enforceable or defensible or infringe or allegedly infringe on rights of others or can withstand claims of invalidity and whether the company can finance or devote other significant resources that may be necessary to prosecute, protect or defend them, the level of corporate expenditures, assessments of the company's technology by potential corporate or other partners or collaborators, capital market conditions, our ability to successfully integrate Inovio and VGX Pharmaceuticals, the impact of government healthcare proposals and other factors set forth in our Annual Report on Form 10-K for the year ended December 31, 2010 and other regulatory filings from time to time. There can be no assurance that any product in Inovio's pipeline will be successfully developed or manufactured, that final results of clinical studies will be supportive of regulatory approvals required to market licensed products, or that any of the forward-looking information provided herein will be proven accurate.

(Logo: http://photos.prnewswire.com/prnh/20110127/LA37605LOGO)

CONTACTS:

Investors: Bernie Hertel, Inovio Pharmaceuticals 858-410-3101 bhertel@inovio.com

Media: Jeff Richardson, Richardson & Associates 805-491-8313 jeff@richardsonglobalpr.com


'/>"/>
SOURCE Inovio Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Inovio Pharmaceuticals Enters Phase II Clinical Trial with SynCon™ DNA Vaccine for Cervical Dysplasia Caused by HPV
2. Inovio Pharmaceuticals Foot-and-Mouth Disease DNA Vaccine Introduces Critical Advantages in Fight Against Most Serious Farm Animal Disease
3. Inovio Pharmaceuticals to Present at 13th Annual BIO CEO & Investor Conference
4. Vanda Pharmaceuticals Reports First Quarter 2011 Results
5. MAP Pharmaceuticals Reports First Quarter of 2011 Financial Results
6. Anadys Pharmaceuticals to Report First Quarter 2011 Financial Results
7. Keryx Biopharmaceuticals, Inc. Announces First Quarter 2011 Financial Results
8. Keryx Biopharmaceuticals, Inc. To Host Conference Call on First Quarter 2011 Financial Results
9. Keryx Biopharmaceuticals Announces Positive Final Data from Zerenex™ Short-Term Phase 3 Study
10. Optimer Pharmaceuticals and Clinical Investigators to Present Data at Upcoming Medical Meetings
11. Auxilium Pharmaceuticals to Announce First Quarter 2011 Results and Conduct Conference Call on Monday, May 9, 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... One of the major limitations in ... vascular supply. Nutrient and gas transport throughout synthetic ... for successful regeneration and integration into the patient’s ... vascularization and promote angiogenesis in a variety of ... and architecture, and enhancing scaffolds with stem cells. ...
(Date:8/19/2014)... 2014 Research and Markets  has announced the ... Global Strategic Business Report" report to their offering. ... Oxide Fuel Cells (SOFCs) in US$ Thousands. The report provides ... , Europe , Asia-Pacific ... provided for the period 2012 through 2020. Market data and ...
(Date:8/19/2014)... (PRWEB) August 19, 2014 In November 2012, ... Benefit Risk Evaluation Report (PBRER) in a new PSUR – ... post-authorization safety benefit-risk profile of a drug. Adopted in many ... , Present a comprehensive and critical analysis of ... , Highlight any new evidence of the potential ...
(Date:8/18/2014)... 2014) -- A new therapy developed by researchers ... College of Medicine and Columbia University Medical Center ... interventional cardiovascular disease treatment. , The researchers ... molecular therapy could selectively inhibit blood vessel re-narrowing ... procedure using a balloon catheter to open narrowed ...
Breaking Biology Technology:Vascularization in Tissue Engineering Highlighted at 12th New Jersey Symposium on Biomaterials Science 2Global Solid Oxide Fuel Cells (SOFCs) - Strategic Business Report 2014 2Top Five Best Practices for Developing Your Periodic Benefit Risk Evaluation Report (PBRER), New Webinar Hosted by Xtalks 2Selective therapy may improve artery repair after interventional cardiovascular procedures 2Selective therapy may improve artery repair after interventional cardiovascular procedures 3
... from North Carolina State University shows that size plays ... hollow nanoparticles. The researchers focused on nickel nanoparticles, which ... applications in fields as diverse as energy production and ... potential for nanofabrication the creation of materials that ...
... push the boundaries of nanoscience, the Kavli Institute at Cornell ... new ideas, but a proving ground to aggressively push the ... named Paul McEuen, the Goldwin Smith Professor of Physics, as ... engineering physics, will serve as co-director. The institute ...
... Choi of the Department of Mechanical Engineering at Stevens ... the 2010 Young Investigator Program (YIP) award by the ... scientists and engineers who show exceptional promise for creative ... young outstanding scientists and engineers," said ONR,s Director of ...
Cached Biology Technology:Study shows that size affects structure of hollow nanoparticles 2Under new leadership, Kavli Institute at Cornell evolves from a think tank to a proving ground 2Dr. Chang-Hwan Choi honored with prestigious Young Investigator Award 2Dr. Chang-Hwan Choi honored with prestigious Young Investigator Award 3
(Date:8/20/2014)... and its energy is finally utilized for the ... mostly build from silicon based semiconductors, also harness ... the development of cheaper and renewable photovoltaics consists ... protein complexes of photosynthesis. Prof. Dr. Matthias Rgner,s ... cyanobacteria that live in a hot spring in ...
(Date:8/19/2014)... increasing caesarean section rate, suggests a new commentary published ... of Obstetrics and Gynaecology (BJOG) . , China has ... world. Of 16 million babies born in 2010, approximately ... not known, the current Chinese language literature on caesarean ... 36% to 58%. However, before the 1980s, the caesarean ...
(Date:8/19/2014)... release is available in German . ... inherently intermittent energy sources. If a large amount of electricity ... future, excess energy will have to be stored during productive ... existing storage capacities are far from adequate for the purpose. ... One important focus lies on battery systems that used to ...
Breaking Biology News(10 mins):A semi-artificial leaf faster than 'natural' photosynthesis 2Is China's 50 percent cesarean section delivery rate too high? 2Is China's 50 percent cesarean section delivery rate too high? 3Asian inventions dominate energy storage systems 2Asian inventions dominate energy storage systems 3
... A competitive grant is helping a Kansas State University ... of the worst plant diseases into a tool that ... plant pathology doctoral student, Puerto Rico, recently was awarded ... the U.S. Department of Agriculture,s National Institute of Food ...
... signal processing in adaptive arrays and multiple sensor radar, ... Fellow. His work has contributed greatly to the ... Unlike conventional radar in which targets are ... targets are probed with multiple waveforms simultaneously. As ...
... European Parliament,s Committee on Foreign Affairs unanimously concluded ... should be approved. This was reported by the Mission of ... marked yet another step towards the ratification and implementation of ... decision the members of the European Parliament demonstrated consistency in ...
Cached Biology News:USDA grant advancing deadly plant disease, insect research 2NJIT professor Alexander Haimovich named IEEE Fellow 2Ukraine, EU Advance on Visa Facilitation Agreement 2
... The Paragon CZE 2000 Capillary ... automate clinical serum protein electrophoresis (SPE), ... (IFE/s) for fast and accurate analysis. ... almost no sample preparation and no ...
The HQ505, 20 OptiGreen filter for the Molecular Imager FX is a band pass filter used for detection of Cy2 and FITC with 532 nm excitation....
The filter 530DF28 for the Molecular Imager FX is a band pass filter for ECL Plus, AttoPhos, SYBR Green, Alexa Fluor 488, FITC, Cy2, and Pro-Q Emerald dyes....
... In Situ Apoptosis Detection Kit detects ... indirect TUNEL method, utilizing an anti-digoxigenin ... Fluorescein reporter molecule. It provides indirect ... are analyzed using either flow cytometry ...
Biology Products: